About Prosensa Holding NV
Prosensa Holding N.V., formerly Prosensa Holding B.V., is a biotechnology company engaged in the discovery and development of ribonucleic acid-modulating (RNA)-modulating, therapeutics for the treatment of genetic disorders. The Company's primary focus is on rare neuromuscular and neurodegenerative disorders with a large unmet medical need, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. The Company's clinical portfolio of RNA-based product candidates is focused on the treatment of Duchenne muscular dystrophy (DMD). The Company's platform technology allows the development of RNA-modulating therapeutics that either interferes with splicing (exon skipping, exon inclusion, or splice mutation correction), remove mutant RNA, or block RNA expression, for different indications.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Exchange: NYSE
- Symbol: RNA
- Previous Close: $19.00
- 50 Day Moving Average: $19
- 200 Day Moving Average: $14
- 52-Week Range: $4.00 - $23.00
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -19.00
- P/E Growth: 0
- Market Cap: $N/A
Consensus Ratings for Prosensa Holding NV (NYSE:RNA) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Prosensa Holding NV (NYSE:RNA)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Prosensa Holding NV (NYSE:RNA)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Earnings Estimates for Prosensa Holding NV (NYSE:RNA)
Current Year EPS Consensus Estimate: $-1 EPS
Next Year EPS Consensus Estimate: $-1 EPS
Dividend History for Prosensa Holding NV (NYSE:RNA)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Prosensa Holding NV (NYSE:RNA)
No insider trades for this company have been tracked by MarketBeat.com
Latest Headlines for Prosensa Holding NV (NYSE:RNA)
What is Prosensa Holding NV's stock symbol?
Prosensa Holding NV trades on the New York Stock Exchange (NYSE) under the ticker symbol "RNA."
How do I buy Prosensa Holding NV stock?
Shares of Prosensa Holding NV can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Prosensa Holding NV stock cost?
One share of Prosensa Holding NV stock can currently be purchased for approximately $19.00.
Prosensa Holding NV (NYSE:RNA) Chart for Monday, February, 27, 2017
Institutional Ownership ChartEarnings History ChartDividend History Chart